These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 32877539)

  • 1. Infectious Diseases and Injection Drug Use: Public Health Burden and Response.
    Levitt A; Mermin J; Jones CM; See I; Butler JC
    J Infect Dis; 2020 Sep; 222(Suppl 5):S213-S217. PubMed ID: 32877539
    [No Abstract]   [Full Text] [Related]  

  • 2. Controlling disease transmission in injection drug users.
    Kane B
    Ann Intern Med; 1999 Mar; 130(6):541-4. PubMed ID: 10075630
    [No Abstract]   [Full Text] [Related]  

  • 3. A new day for African public health.
    The Lancet Infectious Diseases
    Lancet Infect Dis; 2017 Mar; 17(3):237. PubMed ID: 28244376
    [No Abstract]   [Full Text] [Related]  

  • 4. Harm reduction drug policy.
    Voth EA
    Lancet Infect Dis; 2008 Sep; 8(9):528; author reply 528-9. PubMed ID: 18718436
    [No Abstract]   [Full Text] [Related]  

  • 5. Harm reduction in the health care system: the legality of prescribing and dispensing syringes to drug users.
    Burris S; Lurie P; Ng M
    Health Matrix Clevel; 2001; 11(1):5-64. PubMed ID: 11345676
    [No Abstract]   [Full Text] [Related]  

  • 6. An enduring reminder of the importance of public health.
    The Lancet Infectious Diseases
    Lancet Infect Dis; 2018 Jan; 18(1):1. PubMed ID: 29303726
    [No Abstract]   [Full Text] [Related]  

  • 7. Making the case for harm reduction programs for injection drug users.
    Kulikowski J; Linder E
    Nursing; 2018 Jun; 48(6):46-51. PubMed ID: 29794629
    [No Abstract]   [Full Text] [Related]  

  • 8. A career in a Kingdom: Journeys in infection, Mass Gathering Medicine and public health diplomacy.
    Memish Z
    Hum Vaccin Immunother; 2017 Mar; 13(3):494-498. PubMed ID: 27559845
    [No Abstract]   [Full Text] [Related]  

  • 9. Conference on "Emerging Infectious Diseases: Meeting the Challenge".
    Hughes JM
    Emerg Infect Dis; 1995; 1(3):101. PubMed ID: 8903175
    [No Abstract]   [Full Text] [Related]  

  • 10. Global infectious diseases - the new norm for the United States?
    McFee RB
    Dis Mon; 2013 Dec; 59(12):426-33. PubMed ID: 24314804
    [No Abstract]   [Full Text] [Related]  

  • 11. Infectious disease, injection practices, and risky sexual behavior among anabolic steroid users.
    Ip EJ; Yadao MA; Shah BM; Lau B
    AIDS Care; 2016; 28(3):294-9. PubMed ID: 26422090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The genesis of syringe prescription to prevent HIV in Rhode Island.
    Rich JD; McKenzie M; Macalino G; Runnarsdottir V; Gaydos M; Mehrotra M; Stein J; Whitlock T; Salas C; Burris S
    Health Matrix Clevel; 2001; 11(1):129-45. PubMed ID: 11345673
    [No Abstract]   [Full Text] [Related]  

  • 13. Changes in Reported Injection Behaviors Following the Public Health Response to an HIV Outbreak Among People Who Inject Drugs: Indiana, 2016.
    Dasgupta S; Broz D; Tanner M; Patel M; Halleck B; Peters PJ; Weidle PJ; O'Donnell J; Amlung J; McAlister C; Chapman E; Bailey A; Burnett J; Duwve J
    AIDS Behav; 2019 Dec; 23(12):3257-3266. PubMed ID: 31313095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Harm reduction theories and strategies for control of human immunodeficiency virus: a review of the literature.
    Hilton BA; Thompson R; Moore-Dempsey L; Janzen RG
    J Adv Nurs; 2001 Feb; 33(3):357-70. PubMed ID: 11251723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of public health service in prevention and control of infectious diseases in the Federal Republic of Germany. Tasks, structures and responsibilities--an overview].
    Wirtz A; Andres M; Gottschalk R; Stark S; Weber HJ
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Sep; 48(9):971-8. PubMed ID: 16160884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Laboratory Equipment Manufacturer Policies on Highly Hazardous Communicable Diseases.
    Herstein JJ; Buehler SA; Le AB; Lowe JJ; Iwen PC; Gibbs SG
    Public Health Rep; 2019; 134(4):332-337. PubMed ID: 31216938
    [No Abstract]   [Full Text] [Related]  

  • 17. [Social networks, risk dyads, and their role in the epidemiology and prevention of drug related infectious diseases].
    Gyarmathy VA; Rácz J
    Orv Hetil; 2010 Aug; 151(32):1289-94. PubMed ID: 20656668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Networking for health protection: the Communicable Diseases Network Australia.
    Lindenmayer P
    Commun Dis Intell Q Rep; 2001 Nov; 25(4):266-9. PubMed ID: 11806661
    [No Abstract]   [Full Text] [Related]  

  • 19. A policy-maker's perspective on 'ECDC and EMCDDA guidance: prevention and control of infectious diseases among people who inject drugs'.
    Colom i Farran J
    BMC Infect Dis; 2014; 14 Suppl 6(Suppl 6):S11. PubMed ID: 25253290
    [No Abstract]   [Full Text] [Related]  

  • 20. The epidemics of injecting drug use and blood-borne disease: a public health perspective.
    Gostin LO
    Spec Law Dig Health Care Law; 1998 Jun; (231):9-40. PubMed ID: 10181048
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.